Enliven Therapeutics, Inc. (ELVN)
45.17
-0.92
(-2.00%)
USD |
NASDAQ |
Sep 24, 16:00
45.20
+0.03
(+0.07%)
After-Hours: 19:59
Enliven Therapeutics Gross Profit (Annual) : -0.263M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.263M |
| December 31, 2024 | -0.317M |
| December 31, 2023 | -0.297M |
| December 31, 2022 | -0.622M |
| December 31, 2021 | -0.115M |
| Date | Value |
|---|---|
| December 31, 2020 | -0.097M |
| December 31, 2019 | -0.033M |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Definium Therapeutics, Inc. | 0.00 |
| Cocrystal Pharma, Inc. | -0.376M |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 257.40M |